Black Diamond Therapeutics
BDTX
BDTX
96 hedge funds and large institutions have $212M invested in Black Diamond Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
38
Reduced
21
Closed
16
Calls
$7.05M
Puts
$9.61M
Net Calls
-$2.56M
Net Calls Change
-$2.78M
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
+$12.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.04M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.03M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$2.58M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.24M |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$4.88M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$3.89M |
| 3 |
Millennium Management
New York
|
-$3.38M |
| 4 |
SC
Stempoint Capital
New York
|
-$3.14M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$3.03M |
